Search results for " Ni"

showing 10 items of 3074 documents

Intake of Tomato-Enriched Diet Protects from 6-Hydroxydopamine-Induced Degeneration of Rat Nigral Dopaminergic Neurons

2009

There is extensive evidence that oxidative damage of dopamine (DA)-containing neurons in the substantia nigra pars compacta (SNc) may contribute to the pathogenesis of Parkinson’s disease (PD). We evaluated the potential neuroprotective effect of diets enriched with wild-type Red Setter (RS) tomato or transgenic High Carotene (HC) tomato, rich in β-carotene, obtained by the activation of lycopene β-cyclase (tlcy-b), in an animal model of PD. Male Fischer 344 rats were fed for 14 days with standard AltrominMT diet, 5% RS- or 5% HC-enriched diet. Seven days after the beginning of this diet regimen, the rats were lesioned by 6-hydroxydopamine (6-OHDA) injected into the left SNc. After further …

medicine.medical_specialtyHydroxydopamineChemistryPars compactamedicine.medical_treatmentDopaminergicCaroteneSubstantia nigraStriatumLycopenechemistry.chemical_compoundEndocrinologyDopamineInternal medicinemedicinemedicine.drug
researchProduct

Inhaled nitric oxide as a rescue therapy in a preterm neonate with severe pulmonary hypertension: a case report

2018

Abstract Background Inhaled nitric oxide (iNO) has been approved for the treatment of persistent pulmonary hypertension of the newborn (PPHN) in term and near-term newborns. Its role in the management of persistent pulmonary hypertension in preterm infants is not clear. Although guidelines do not exist, some studies have shown that iNO could be used as a rescue therapy in preterm neonate with severe pulmonary hypertension. Case presentation We describe the case of a preterm neonate, born at 30 + 1 weeks of gestation, with hypoxic respiratory failure not responding to maximal conventional therapy. On the third day of life echocardiography showed severe pulmonary hypertension with right to le…

medicine.medical_specialtyHypertension PulmonaryRight-to-left shuntDay of lifeCase ReportInfant Premature DiseasesNitric OxidePulmonary hypertensionNitric oxide03 medical and health scienceschemistry.chemical_compound0302 clinical medicineRescue therapy030225 pediatricsInternal medicinemedicine.arteryAdministration InhalationHumansMedicine030212 general & internal medicinebusiness.industryPersistent pulmonary hypertensionPreterm neonatelcsh:RJ1-570Infant Newbornlcsh:PediatricsGeneral Medicinemedicine.diseasePulmonary hypertensionBronchodilator AgentschemistryRespiratory failureCardiologyGestationFemalebusinessInfant PrematureInhaled nitric oxideItalian Journal of Pediatrics
researchProduct

The clinical relevance of non-classified dysganglionoses and implications for a new grading system

2001

In addition to the classified types of dysganglionosis, certain non-classified dysganglionoses (NCD) (types 1-4) were introduced by Meier-Ruge in 1992. Clinical data on these conditions are limited. Among 134 children with intestinal dysganglionoses (ID) treated from 1979 to 1999, 12 were identified to have a NCD. Their clinical course is presented. The existence of mild ID (type 1) is difficult to demonstrate. Current definitions and data on clinical relevance are not convincing. An indication for surgical treatment is not present. Isolated hypogenesis of the submucous plexus (SMP) (type 2, n = 8) is clinically a more severe kind of intestinal neuronal dysplasia type B and often requires e…

medicine.medical_specialtyIntestinal neuronal dysplasiabusiness.industryDysganglionosisSubmucous PlexusGeneral Medicinemedicine.diseaseGastroenterologySurgeryColonic DiseasesText miningEl NiñoInternal medicinePediatrics Perinatology and Child HealthPediatric surgerymedicineSubmucous plexusHumansGangliaSurgeryClinical significanceChildbusinessDigestive System AbnormalitiesMyenteric plexusPediatric Surgery International
researchProduct

Modifications induced on the amygdaloid paroxysmal activity by entopeduncolar or nigral injection of kainic acid, in the cat.

1983

Entopeduncolar or nigral injection of kainic acid determines an early decrease of the evoked amygdaloid paroxysmal activity and a later increase of the after discharge duration. This biphasic effect is likely due to the structural analogy of the drug with monosodium glutamate, a neuroexcitant amino acid. The data suggest that the basal ganglia exert a tonic control on the amygdaloid activity.

medicine.medical_specialtyKainic acidPyrrolidinesTime FactorsPhysiologyMonosodium glutamateBiologyBiochemistryTonic (physiology)chemistry.chemical_compoundEpilepsyInternal medicineBasal gangliamedicineCarnivoraAnimalschemistry.chemical_classificationDecerebrate StateKainic AcidFissipediabiology.organism_classificationmedicine.diseaseAmygdalaAmino acidElectrophysiologySubstantia NigraEndocrinologynervous systemchemistryCatsArchives internationales de physiologie et de biochimie
researchProduct

Acanthosis nigricans: A review.

2020

Background Acanthosis nigricans (AN) is a cutaneous disorder characterized by symmetric velvety hyperpigmented plaques on intertriginous areas like axilla, neck, inframammary, and groin. Aims To summarize the pathophysiology and classification of AN, provide an update of diagnostic testing strategies, and describe the current therapeutic options described so far in the literature for this disease. Methods A comprehensive english language literature search across multiple databases (PubMed, EMBASE, MEDLINE, and Cochrane) for keywords (alone and in combination) was performed. MeSH as well as non-MeSH terms such as "acanthosis nigricans," "classification," "pathophysiology," "diagnosis," "trea…

medicine.medical_specialtyKeratolyticMEDLINEDermatologyDiseaseIntertriginous030207 dermatology & venereal diseases03 medical and health sciencesRetinoids0302 clinical medicinemedicineInframammary foldHumansAcanthosis NigricansObesityVitamin DAcanthosis nigricansbusiness.industrymedicine.diseaseDermatologyAxillamedicine.anatomical_structure030220 oncology & carcinogenesisChemical peelingInsulin ResistancebusinessJournal of cosmetic dermatologyREFERENCES
researchProduct

Surgical sphincter saving approach and topical nifedipine for chronic anal fissure with hypertonic internal anal sphincter

2020

PURPOSE The role of augmented internal anal sphincter (IAS) tone in the genesis of posterior chronic anal fissure (CAPF) is still unknown. Lateral internal sphincterotomy is the most employed surgical procedure, nevertheless it is burdened by high risk post-operative anal incontinence. The aim of our study is to evaluate results of sphincter saving procedure with post-operative pharmacological sphincterotomy for patients affected by CAPF with IAS hypertonia. Methods: We enrolled 30 patients, undergone fissurectomy and anoplasty with V-Y cutaneous flap advancement; all patients received topical administration of nifedipine 0.3% and lidocaine 1.5% ointment-based therapy before and for 15 days…

medicine.medical_specialtyLidocaineNifedipinemedicine.medical_treatmentAdministration TopicalAnal CanalSurgical FlapsInternal anal sphincterFissurectomyOintmentsMuscle HypertoniaNifedipineMuscle HypertoniamedicineHumansProspective StudiesAnesthetics LocalAnestheticsAnal fissureAnal fissure Anoplasty Fissurectomy Lidocaine Nifedipine Proctology Administration Topical Anal Canal Anesthetics Local Calcium Channel Blockers Chronic Disease Combined Modality Therapy Humans Lidocaine Muscle Hypertonia Ointments Prospective Studies Surgical Flaps Treatment Outcome Fissure in Ano Nifedipinebusiness.industryLidocaineAnal canalAnoplastymedicine.diseaseCalcium Channel BlockersCombined Modality TherapySurgerymedicine.anatomical_structureTreatment OutcomeTopicalLocalAdministrationChronic DiseaseHypertoniaSurgeryFissure in Anomedicine.symptomAnal fissureProctologyLateral internal sphincterotomybusinessmedicine.drug
researchProduct

Comparison of two delayed strategies for renal replacement therapy initiation for severe acute kidney injury (AKIKI 2): a multicentre, open-label, ra…

2021

International audience; BACKGROUND: Delaying renal replacement therapy (RRT) for some time in critically ill patients with severe acute kidney injury and no severe complication is safe and allows optimisation of the use of medical devices. Major uncertainty remains concerning the duration for which RRT can be postponed without risk. Our aim was to test the hypothesis that a more-delayed initiation strategy would result in more RRT-free days, compared with a delayed strategy. METHODS: This was an unmasked, multicentre, prospective, open-label, randomised, controlled trial done in 39 intensive care units in France. We monitored critically ill patients with severe acute kidney injury (defined …

medicine.medical_specialtyMESH: Acute Kidney Injury[SDV]Life Sciences [q-bio]medicine.medical_treatmentPopulation030204 cardiovascular system & hematologyurologic and male genital diseasesMESH: Severity of Illnes Index03 medical and health sciencesMESH: Aged 80 and over0302 clinical medicineOliguriaIntensive careInternal medicineMedicineMESH: Time-to-Treatment030212 general & internal medicineRenal replacement therapyeducationBlood urea nitrogenMESH: Agededucation.field_of_studyMESH: HumansMESH: Middle Agedbusiness.industryHazard ratioAcute kidney injuryGeneral Medicinemedicine.diseaseMESH: MaleMESH: Prospective Studies3. Good health[SDV] Life Sciences [q-bio]MESH: FranceMESH: Intensive Care Unitsmedicine.symptomMESH: Renal Remplacement TherapybusinessMESH: FemaleKidney diseaseThe Lancet
researchProduct

High-Speed Video Microscopy for Primary Ciliary Dyskinesia Diagnosis: A Study of Ciliary Motility Variations with Time and Temperature

2021

Este artículo se encuentra disponible en la siguiente URL: https://www.mdpi.com/2075-4418/11/7/1301 Este artículo de investigación pertenece al número especial "Progress in Diagnosing and Managing Primary Ciliary Dyskinesia". Primary ciliary dyskinesia (PCD) is a rare disease resulting from a defect in ciliary function that generates, among other issues, chronic upper and lower respiratory tract infections. European guidelines recommend studying ciliary function (pattern (CBP) and frequency (CBF)), together with characteristic clinical symptoms, as one of the definitive tests. However, there is no “gold standard”. The present study aims to use high-speed video microscopy to describe how CBF…

medicine.medical_specialtyMedicine (General)Kartagener's syndrome - Diagnosis.Respiratory organs - Diseases in children.Clinical BiochemistryAparato respiratorio - Enfermedades en los niños.Video microscopyArticlehigh-speed video microscopy (HSVM)03 medical and health sciences0302 clinical medicineR5-920ciliary beat frequency (CBF)Microscopia.OphthalmologyMicroscopy.MicroscopymedicinePediatric otolaryngology.030212 general & internal medicinePrimary ciliary dyskinesiaDisquinesia ciliar Síndrome de - Diagnóstico.primary ciliary dyskinesia (PCD)business.industryPrimary ciliary dyskinesia - Diagnosis.Enfermedades crónicas en los niños.Otorrinolaringología pediátrica.Gold standard (test)Ciliary motilitymedicine.diseaseNasal epitheliumChronic diseases in children.ciliary beat pattern (CBP)High speed video030228 respiratory systemKartagener Síndrome de - Diagnóstico.Sample collectionbusiness
researchProduct

COVID-19 and Alzheimer’s Disease

2021

The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a neurotropic virus with a high neuroinvasive potential. Indeed, more than one-third of patients develop neurological symptoms, including confusion, headache, and hypogeusia/ageusia. However, long-term neurological consequences have received little interest compared to respiratory, cardiovascular, and renal manifestations. Several mechanisms have been proposed to explain the potential SARS-CoV-2 neurological injury that could lead to the development of neurodegenerative diseases, including Alzheimer’s Disease (AD). A mutualistic relationship between AD and COVID-19 seems to exist. On the one hand, COVID-19 patients seem to …

medicine.medical_specialtyNeurological injuryCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)neuroinflammation.DiseaseReviewneuroinflammationlcsh:RC321-57103 medical and health sciences0302 clinical medicineMedicineIntensive care medicinelcsh:Neurosciences. Biological psychiatry. NeuropsychiatryNeuroinflammation030304 developmental biologyNeurotropic virus0303 health sciencesneurodegenerative niseasebusiness.industrySARS-CoV-2General NeuroscienceHypogeusianervous systembiomarkersADAgeusiabiomarkermedicine.symptombusiness030217 neurology & neurosurgeryBrain Sciences
researchProduct

Real world experience with teriflunomide in multiple sclerosis: the TER-Italy study.

2021

Objective: To identify baseline factors associated with disease activity in patients with relapsing–remitting multiple sclerosis (RRMS) under teriflunomide treatment. Methods: This was an independent, multi-centre, retrospective post-marketing study. We analysed data of 1,507 patients who started teriflunomide since October 2014 and were regularly followed in 28 Centres in Italy. We reported the proportions of patients who discontinued treatment (after excluding 32 lost to follow-up) and who experienced clinical disease activity, i.e., relapse(s) and/or confirmed disability worsening, as assessed by the Expanded Disability Status Scale (EDSS). Decision tree-based analysis was performed to i…

medicine.medical_specialtyNeurologyMultiple SclerosisToluidinesHydroxybutyratesOral drugsDiseaseRelapsing-RemittingSettore MED/26Pregnancy planning03 medical and health scienceschemistry.chemical_compound0302 clinical medicineMultiple Sclerosis Relapsing-RemittingInternal medicineTeriflunomideTeriflunomideNitrilesmedicineHumans030212 general & internal medicineAdverse effectRetrospective StudiesExpanded Disability Status Scalebusiness.industryMultiple sclerosismedicine.diseaseSettore MED/26 - NEUROLOGIANeurologychemistryTolerabilityItalyMultiple sclerosis; Oral drugs; Teriflunomide; Crotonates; Humans; Hydroxybutyrates; Italy; Nitriles; Retrospective Studies; Toluidines; Multiple Sclerosis; Multiple Sclerosis Relapsing-RemittingCrotonatesNeurology (clinical)business030217 neurology & neurosurgeryJournal of neurology
researchProduct